BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Drug Discovery

Cresset and Enamine Expand Global Collaboration to Enhance Targeted Protein Degradation Research

Cresset, an innovative provider of integrated in silico solutions for drug discovery, announces an extension of the global collaboration with Ena...

August 06, 2024 | News

Medicilon and Hengrui Pharma Forge Strategic Partnership to Accelerate Preclinical Drug Development

Shanghai Medicilon Inc. ("Medicilon") and Jiangsu Hengrui Pharmaceuticals Co., Ltd. ("Hengrui Pharma") reached a strategic collaboration agreement.&nb...

August 01, 2024 | News

$2 Million Grant Fuels Queensland Drug Discovery Alliance to Propel Therapeutic Innovations

A $2 million grant awarded to establish the Queensland Drug Discovery Alliance (QDDA) will align and grow Queensland’s small molecule therapeutic dis...

July 31, 2024 | News

Clarivate Launches Enhanced OFF-X™ Platform to Transform Drug Safety Intelligence

Clarivate Plc a leading global provider of transformative intelligence, today announced the launch of the new OFF-X™ platform. The en...

July 31, 2024 | News

ReviR Therapeutics Secures $30M Series A Financing to Advance AI-Driven RNA Modulator Platform

ReviR Therapeutics, an AI-enabled biotechnology company focused on developing small molecule RNA modulators for neurogenetic diseases, announced today that...

July 29, 2024 | News

IASO Biotechnology's IND Application for IASO-782 Injection Approved by NMPA for Systemic Lupus Erythematosus Treatment

IASO Biotechnology ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therap...

July 26, 2024 | News

Innovent Biologics Announces Strategic AI Partnership with WeComput to Enhance Drug Discovery

Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...

July 26, 2024 | News

QDX and Prelude Therapeutics Join Forces to Target Previously Undrugged Oncology Targets

QDX, a computational drug discovery company, announced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology company, targeti...

July 23, 2024 | News

Mabwell's Novel Nectin-4 ADC Approved for Phase II Clinical Trial in Treating Triple-Negative Breast Cancer

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821)...

July 16, 2024 | News

Everest Medicines Announces Positive Topline Data from Phase 3 Trial of Etrasimod for Ulcerative Colitis in Asia

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing an...

July 16, 2024 | News

BioGeometry and Sanyou Bio Forge Strategic Partnership to Innovate Antibody Drug Discovery

BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry is a digital biology pioneer company that spe...

July 12, 2024 | News

Eisai and Biogen Announce Approval of LEQEMBI® (Lecanemab) for Alzheimer’s Disease Treatment in Hong Kong

LEQEMBI is now available for patients with mild cognitive impairment (MCI) or mild dementia, collectively referred to as early AD, the population in which ...

July 11, 2024 | News

DP Technology Nominates DPT0416 as Preclinical Candidate for Alzheimer’s Disease Treatment

DP Technology, an "AI for Science" paradigm-driven company, announced the nomination of DPT0416, a novel CNS penetrable small molecule targeting Lp-P...

July 10, 2024 | News

A*STAR and SingHealth Collaborate on SGD$18 Million TISHUMAP Project to Transform Drug Discovery in Asia

A*STAR’s Genome Institute of Singapore (GIS) has secured nearly SGD$18 million to develop an innovative data platform, TISHUMAP1. This platform is se...

July 09, 2024 | News

Stay Connected